Skip to main content

Ke Cheng

NIH Rank #1868
  • R01 Holder
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10806178Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biomedical Engineering

NIH Funding · FY2024

Linked Award Amount
$3.7M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#1,868
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ke Cheng. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Ke Cheng as a PI. Multi-PI records show the full award amount for context.

  • 5R01HL154154-05R01
    Drug Delivery and Biomimetic Approaches for Optimal Stem Cell Therapy
    $800.2K
    award amount
  • 1R01HL170612-01A1R01
    Inhalable stem cell exosome therapy for cardiac injury
    $752K
    award amount
  • 5R01HL144002-06R01
    Harnessing Platelet-Endothelial Interactions for Exosome Delivery
    $735.9K
    award amount
  • 2R01HL140562-05R01
    Bioresorbable zinc-based drug-eluting stents for pediatric cardiovascular applications
    $733.9K
    award amount
  • 5R01HL146153-06R01
    Developing Long Noncoding RNA Therapy for Precision Cardiac Repair
    $646.6K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Ke Cheng as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Columbia University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1868
  6. 2024
    Entered Top 25% Nationally
    Ranked #1868
  7. 2024
    Entered Top 10% Nationally
    Ranked #1868
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Ke Cheng.